Committed under
Loxagen Inc
$482,115 committed in all years on record · 0.0% of the program
- Full records
- Loxagen Inc → everything they’re paid, across every program and agencyExtramural Research Programs in the Neurosciences and Neurological Disorders → the whole program, every recipientDepartment of Health and Human Services → everything they pay out
By fiscal year
Extramural Research Programs in the Neurosciences and Neurological Disorders dollars committed to Loxagen Inc, per fiscal year.
* FY2026 is year-to-date — the fiscal year is still in progress, so its total is still filling in. The striped band and dashed line mark that provisional stretch.
Awards
The largest awards to Loxagen Inc under this program.
Testing the Lipoxygenase Inhibitor BPN-27332 as Acute Phase Stroke Treatment in the Span Network - the Goal of This Project Is to Evaluate a…
Apr 22, 2026$993,388
A Novel Targeted Therapy for Subarachnoid Hemorrhage - Summary the Goal of This Project Is to Develop a Therapeutic Capable of Treating Suba…
How to read these numbers
- Just these two
Every figure is money committed to this recipient under this one program — nothing they get anywhere else, from this program or any other.
- Totals by action year
The aggregates reflect the fiscal year picked at the top, counted in the year each action happened.
- “Active in FY X”
The award list shows every award between the two with an action that year, at its full lifetime value — so a single award's amount can top that year's committed total.
- From FY2018 on
Pairing pages start at fiscal year 2018, the first year of complete assistance reporting.
- The colored bars
Every bar on this page splits by how the money moves:
Direct paymentsGrants